Physician

Anton M Kolomeyer, MD, PHD

According to 2025 Medicare claims, Anton Kolomeyer, MD, PHD (NPI: 1245573864) practices ophthalmology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 08361-7802. Kolomeyer is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Kolomeyer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 984 traditional Medicare patients, billed 24,305 HCPCS/CPT codes, and received $2,823,761 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 755 prescription claims across 239 beneficiaries totaling $52,580 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 111 records totaling $77,858. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,846 to $2,823,761. Similarly, Part D prescription costs have risen steadily, from $1,728 to $52,580. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2017 Medicare payment: $3,846 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $218,385 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $912,425 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,253,318 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,618,515 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,434,669 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,901,094 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,823,761 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20176473$3,846
20182901,286$218,385
20191,1046,776$912,425
20201,1037,967$1,253,318
20211,2439,219$1,618,515
20221,3338,320$1,434,669
202396320,708$1,901,094
202498424,305$2,823,761

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2015 Drug cost: $1,728 (USD; Tot_Drug_Cst)2016 Drug cost: $4,012 (USD; Tot_Drug_Cst)2017 Drug cost: $19,872 (USD; Tot_Drug_Cst)2018 Drug cost: $21,736 (USD; Tot_Drug_Cst)2019 Drug cost: $28,707 (USD; Tot_Drug_Cst)2020 Drug cost: $50,245 (USD; Tot_Drug_Cst)2021 Drug cost: $55,678 (USD; Tot_Drug_Cst)2022 Drug cost: $52,338 (USD; Tot_Drug_Cst)2023 Drug cost: $36,435 (USD; Tot_Drug_Cst)2024 Drug cost: $52,580 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151326$1,728
20163975$4,012
2017112263$19,872
2018113279$21,736
2019132343$28,707
2020191597$50,245
2021197625$55,678
2022216643$52,338
2023218649$36,435
2024239755$52,580

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0177Injection, aflibercept hd, 1 mg1704,368$263
67028Injection of drug into eye3171,152$98
92014Established patient complete exam of visual system8542,025$95
92134Imaging of retina8692,080$32
92202Extended exam of the back part of the eye with optic nerve drawing5851,022$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1919,096$9,548
LatanoprostLatanoprost16810,313$2,441
Atropine SulfateAtropine Sulfate452,323$1,952
DifluprednateDifluprednate19399$1,574
Ketorolac TromethamineKetorolac Tromethamine471,621$1,049

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.106$71,827Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.5$6,031F. Hoffmann-La Roche AG
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anton M. Kolomeyer, MD, PHD?

Tedicare shows public-source Medicare data for Anton M. Kolomeyer, MD, PHD (NPI 1245573864), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anton M. Kolomeyer, MD, PHD have ACO affiliation data?

Anton M. Kolomeyer, MD, PHD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Anton M. Kolomeyer, MD, PHD?

Anton M. Kolomeyer, MD, PHD is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Anton M. Kolomeyer, MD, PHD have Open Payments data?

Anton M. Kolomeyer, MD, PHD has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.